UNSPSC 51332103: Levosulpiride or sulpiride

This classification denotes a dopamine antagonist with the molecular formula C15H23N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7MNE9M8287, chemically known as o-anisamide, n-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-, (s)-(-)- but generally known as sulpiride, which bears US NIH Compound Identifier 5355. European Medicines Agency schedules Sulpiride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10758MIG.

UNSPSC 51332103 Levosulpiride or sulpiride is a Commodity code, but the recent state and local procurement activity tagged under it does not align with the code's pharmaceutical scope — the single posted opportunity solicits naloxone and drug deactivation systems, which fall outside the levosulpiride or sulpiride product family. The mismatch suggests either a data-tagging error in the source or a misclassification in the state and local procurement system that generated the record. State and local governments buying under this code should expect pharmaceutical procurement for levosulpiride or sulpiride products; the naloxone solicitation does not represent typical activity under this Commodity code.

Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The procurement carried a response deadline of July 26, 2023, at 2:00 pm, requires bidders to include all shipping and delivery costs, and awards an initial two-year term with an option for one-year renewal. The contract includes probationary termination rights, standard insurance requirements, E-Verify compliance, and potential FEMA funding with attendant federal environmental compliance obligations. No explicit set-aside or disadvantaged-enterprise designations are noted. Given the mismatch between the code name and the opportunity's actual scope, firms should verify code assignment with issuing authorities before pursuing opportunities tagged under this Commodity.